|
Volumn 5, Issue 4, 1998, Pages 181-187
|
Bisphosphonates for bone metastases in breast cancer patients: Trial design issues and evaluation of published studies
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BISPHOSPHONIC ACID DERIVATIVE;
CLODRONIC ACID;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
EPIRUBICIN;
FLUOROURACIL;
METHOTREXATE;
PAMIDRONIC ACID;
ANTINEOPLASTIC ACTIVITY;
BONE METASTASIS;
BREAST CANCER;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG INDICATION;
DRUG MECHANISM;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
META ANALYSIS;
PRACTICE GUIDELINE;
REVIEW;
|
EID: 0031766391
PISSN: None
EISSN: 17187729
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (8)
|
References (31)
|